Avidity Partners Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-117,000
| Closed | -$3.77M | – | 86 |
|
|
2024
Q2 | $3.77M | Sell |
117,000
-244,400
| -68% | -$7.87M | 0.16% | 76 |
|
|
2024
Q1 | $14M | Buy |
361,400
+37
| +0% | +$1.44K | 0.45% | 58 |
|
|
2023
Q4 | $11.1M | Buy |
361,363
+11,163
| +3% | +$344K | 0.41% | 58 |
|
|
2023
Q3 | $7.83M | Sell |
350,200
-3,900
| -1% | -$87.2K | 0.32% | 69 |
|
|
2023
Q2 | $7.61M | Sell |
354,100
-31,400
| -8% | -$675K | 0.27% | 77 |
|
|
2023
Q1 | $9.25M | Buy |
385,500
+347,602
| +917% | +$8.34M | 0.31% | 65 |
|
|
2022
Q4 | $879K | Buy |
+37,898
| New | +$879K | 0.02% | 80 |
|
|
2021
Q2 | – | Sell |
-740,000
| Closed | -$17.5M | – | 126 |
|
|
2021
Q1 | $17.5M | Sell |
740,000
-499,000
| -40% | -$11.8M | 0.48% | 62 |
|
|
2020
Q4 | $24.8M | Buy |
1,239,000
+238,600
| +24% | +$4.78M | 0.81% | 45 |
|
|
2020
Q3 | $20.8M | Buy |
+1,000,400
| New | +$20.8M | 0.97% | 30 |
|
|
2020
Q2 | – | Sell |
-17,000
| Closed | -$278K | – | 64 |
|
|
2020
Q1 | $278K | Sell |
17,000
-163,000
| -91% | -$2.67M | 0.04% | 49 |
|
|
2019
Q4 | $3.7M | Buy |
+180,000
| New | +$3.7M | 2.33% | 23 |
|